Yearender: Health | After splash in 2025, weight-loss drugs poised to take off this year Despite limited uptake, weight-loss drugs have topped drug sales in India by value marking a shift in how people perceive conditions such as obesity
The primary difference between them is their approved indications and the dosage strengths available
Premium or Speciality Drips (Glow, Detox, or Performance Drips): 7,000 11,000+ These are top-tier formulations
These symptoms are often temporary and improve as the body adjusts.* Medical Monitoring Recommended: Regular follow-up with your healthcare provider is important to monitor progress, evaluate tolerance, and optimize your wellness plan while using GLP-1/GIP therapy.* Not Appropriate for Everyone: GLP-1/GIP therapy may not be suitable for individuals with certain medical conditions including a history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or severe gastrointestinal disorders